Inspire Medical Systems, Inc.
INSP · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $803 | $625 | $408 | $233 |
| % Growth | 28.5% | 53.2% | 74.7% | – |
| Cost of Goods Sold | $123 | $97 | $66 | $33 |
| Gross Profit | $680 | $528 | $342 | $200 |
| % Margin | 84.7% | 84.5% | 83.8% | 85.7% |
| R&D Expenses | $114 | $117 | $69 | $37 |
| G&A Expenses | $435 | $352 | $0 | $0 |
| SG&A Expenses | $530 | $452 | $321 | $203 |
| Sales & Mktg Exp. | $95 | $100 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $644 | $568 | $389 | $240 |
| Operating Income | $36 | -$40 | -$48 | -$40 |
| % Margin | 4.5% | -6.4% | -11.7% | -17.1% |
| Other Income/Exp. Net | $22 | $20 | $3 | -$2 |
| Pre-Tax Income | $58 | -$20 | -$44 | -$42 |
| Tax Expense | $5 | $1 | $1 | $0 |
| Net Income | $54 | -$21 | -$45 | -$42 |
| % Margin | 6.7% | -3.4% | -11% | -18% |
| EPS | 1.8 | -0.72 | -1.6 | -1.54 |
| % Growth | 350% | 55% | -3.9% | – |
| EPS Diluted | 1.75 | -0.72 | -1.6 | -1.54 |
| Weighted Avg Shares Out | 30 | 29 | 28 | 27 |
| Weighted Avg Shares Out Dil | 31 | 29 | 28 | 27 |
| Supplemental Information | – | – | – | – |
| Interest Income | $23 | $21 | $5 | $0 |
| Interest Expense | $0 | $0 | $2 | $2 |
| Depreciation & Amortization | $7 | $3 | $2 | $1 |
| EBITDA | $65 | -$17 | -$41 | -$39 |
| % Margin | 8.1% | -2.7% | -10% | -16.5% |